Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending September 27, 2020 Hidradenitis suppurativa: Induction therapy with intravenous ustekinumab may be beneficial, Hidradenitis suppurativa linked to childhood and lifetime traumatic events, Low prescription of TNF-α inhibitors in hidradenitis suppurativa, Lymecycline vs. clindamycin plus rifampicin for hidradenitis suppurativa, Hidradenitis suppurativa linked to increased risk of nonalcoholic fatty liver disease, More must reads Must reads for theWeek ending September 20, 2020 High-risk prostate cancer: Outcomes of neurovascular bundle preservation, Prostate cancer: Outcomes of surveillance, prostatectomy, and radiotherapy, mCRPC: Rucaparib demonstrates activity in phase 2, Prostate cancer: Delaying radiotherapy after ADT not linked to poor overall survival, mCRPC: Docetaxel-carboplatin improves outcomes after second-generation hormone therapy, More must readsMust reads for theWeek ending September 6, 2020 New blood-based test for prostate cancer, mCRPC: Survival advantage of enzalutamide maintained in the long term, Perirectal hydrogel spacer may lower prostate radiotherapy-induced rectal toxicities, Radiotherapy after radical prostatectomy worsens sexual, urinary function, Routine use of neoadjuvant chemohormonal therapy not supported in localized high-risk prostate cancer, More must readsMust reads for theWeek ending August 30, 2020 Sarcopenia is a predictor of overall survival in DLBCL patients, Mutation tied to central nervous system collapse in DLBCL, Splenectomy ideal for integrative diagnosis of splenic lymphomas, Novel STAT3 inhibitor affects DLBCL growth, FDA approves new drug for diffuse large B-cell lymphoma, More must readsMust reads for theWeek ending August 23, 2020 Fracture risk in prostate cancer survivors, Radical prostatectomy vs deferred treatment for localized prostate cancer, mHSPC: Antibiotic prophylaxis for febrile neutropenia, Localized prostate cancer: HIFU may be an effective option, Prostate cancer: Ablation yields poor survival vs radiotherapy, More must readsPages1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 last »
